
The Coronavirus
FDA advisory panel recommends Pfizer vaccine for kids ages 5 to 11
Posted on · After some debate, a group of scientists advising the FDA concluded that the vaccine's benefits outweigh its risks for young children.
Posted on · After some debate, a group of scientists advising the FDA concluded that the vaccine's benefits outweigh its risks for young children.
Posted on · The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents.